Cargando…
Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
Duchenne muscular dystrophy (DMD) is a severe muscle-degenerative disease caused by a mutation in the dystrophin gene. Genetic correction of patient-derived induced pluripotent stem cells (iPSCs) by TALENs or CRISPR-Cas9 holds promise for DMD gene therapy; however, the safety of such nuclease treatm...
Autores principales: | Li, Hongmei Lisa, Fujimoto, Naoko, Sasakawa, Noriko, Shirai, Saya, Ohkame, Tokiko, Sakuma, Tetsushi, Tanaka, Michihiro, Amano, Naoki, Watanabe, Akira, Sakurai, Hidetoshi, Yamamoto, Takashi, Yamanaka, Shinya, Hotta, Akitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297888/ https://www.ncbi.nlm.nih.gov/pubmed/25434822 http://dx.doi.org/10.1016/j.stemcr.2014.10.013 |
Ejemplares similares
-
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015) -
A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
por: Uchimura, Tomoya, et al.
Publicado: (2021) -
Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
por: Naidoo, Michael, et al.
Publicado: (2019) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022) -
Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein
por: Kagita, Akihiro, et al.
Publicado: (2021)